Cargando…
Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection
Ischemic heart diseases (IHD) are the leading cause of death worldwide. Although the principal form of treatment of IHD is myocardial reperfusion, the recovery of coronary blood flow after ischemia can cause severe and fatal cardiac dysfunctions, mainly due to the abrupt entry of oxygen and ionic de...
Autores principales: | Caricati-Neto, Afonso, Errante, Paolo Ruggero, Menezes-Rodrigues, Francisco Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720817/ https://www.ncbi.nlm.nih.gov/pubmed/31426434 http://dx.doi.org/10.3390/ijms20164002 |
Ejemplares similares
-
Pharmacological modulation of b-adrenoceptors as a new cardioprotective strategy for therapy of myocardial dysfunction induced by ischemia and reperfusion
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2019) -
Cardioprotective effects of pharmacological blockade of the mitochondrial calcium uniporter on myocardial ischemia-reperfusion injury
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2020) -
Cardioprotection stimulated by resveratrol and grape products
prevents lethal cardiac arrhythmias in an animal model of ischemia and
reperfusion
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2021) -
The mitochondrial calcium uniporter: a new therapeutic target for Parkinson’s disease-related cardiac dysfunctions?
por: Scorza, Fúlvio Alexandre, et al.
Publicado: (2020) -
Pharmacological Modulation of the Ca(2+)/cAMP/Adenosine Signaling in Cardiac Cells as a New Cardioprotective Strategy to Reduce Severe Arrhythmias in Myocardial Infarction
por: Tallo, Fernando Sabia, et al.
Publicado: (2023)